Beta-blockade for patients undergoing vascular surgery [3] (multiple letters)

New England Journal of Medicine

Volumn 342, Issue 14, 2000, Pages 1051-1053

  Feldman, T ^a   Fusman, B ^a   McKinsey, J F ^a   Litwack, R S ^a   Gilligan, D M ^a   DeGruttola, V ^a   Poldermans, D ^a   Boersma, E ^a   Thomson, I R ^a   Lee, T H ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; DOBUTAMINE;

CARDIOVASCULAR RISK; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; LETTER; MEDICAL RESEARCH; METHODOLOGY; MORTALITY; PATIENT SELECTION; PEER REVIEW; PERIOPERATIVE PERIOD; PREMEDICATION; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; VASCULAR SURGERY;

ADRENERGIC BETA-ANTAGONISTS; BISOPROLOL; HUMANS; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PREMEDICATION; RESEARCH DESIGN; VASCULAR SURGICAL PROCEDURES;

EID: 0034611741     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200004063421414     Document Type: Letter

References (0)